Regencell Bioscience Holdings Limited

RGC
$6.37 (- $1.66 - 20.67%)
Last updated: 2026-07-04 01:02 UTC
RGC Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINKYG7487R1002
Market Price6.37
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.01
Market Cap$12.2B
Book Value0.01
Price to Book2460.0
Beta2.06
52w High83.6
52w Low0.09
Next Earnings DateN/A

Regencell Bioscience Holdings Limited trades under ticker RGC on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN KYG7487R1002.

About the Company
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Price History